Scott Schaus, PhD
|Institution||Boston University College of Arts and Sciences|
|Address||24 Cummington Mall|
Boston MA 02215
|Institution||Boston University School of Medicine|
|Department||Pharmacology & Experimental Therapeutics|
Professor Schaus received his Ph.D. in Organic Chemistry with Eric N. Jacobsen at Harvard University in 1999 and did postdoctoral studies in Andy Myers’ laboratory at Harvard University as an NIH fellow.
Research in the Schaus Group is focused in two major areas: enantioselective catalytic synthetic methodologies for chemical synthesis and biomedical research, the latter conducted at the Boston University Center for Molecular Discovery. Catalytic methods developed in the Schaus Research Laboratories include asymmetric Mannich reactions, enantioselective boronate reactions, and metal-promoted condensation reactions.
Asymmetric Mannich Reactions – The use of cinchona amine, acid, and diol catalysis in the synthesis of chiral amines and heterocycles.
Enantioselective Boronate Catalysis – The development of methodologies to construct chiral building blocks and natural products using boronates.
Biomedical Research – In conjunction with the CMD-BU, advance translational science in the treatment of cancer and infectious disease.
Hepatocellular Carcinoma – Taking on liver cancer in the lab.
Neglected Tropical Disease – BU Researchers Work against Deadly, Disfiguring Disease. Pharmaceutical giant GSK chooses team in its new competition.
Techniques & Resources:
Organic Synthesis techniques are used and include modern methods for synthesis, purification, and analysis of organic molecules.
The Center for Molecular Discovery (CMD-BU) is an NIH-funded Center at Boston University which focuses on development of new methodologies for the synthesis of chemical libraries and biomedical research.
Click the "See All" links for more information and interactive visualizations!
Similar BU People
BU People who are also in this person's primary department.